Skip to Main Content
Don't have an account? Create Account
x
Don't have an account? Create Account

Andrea Lugo

Communications Associate

Andrea Lugo is a communications associate at America's Essential Hospitals.

Pfizer-BioNTech and Moderna data indicate that bivalent vaccines provide greater protection than the original monovalent vaccine against the emerging BQ.1.1 omicron subvariant, while the CDC reports low COVID-19 vaccination numbers among children.

view more »

A JAMA Network open study highlights disparities in access to Test-to-Treat sites; the Biden administration holds a White House COVID-19 Equity Summit.

view more »

A new report from the Department of Veterans Affairs indicates that Paxlovid can reduce risk of long COVID-19; new data show Pfizer bivalent COVID-19 booster vaccines substantially increase immune responses compared with monovalent vaccines.

view more »

President Joe Biden urges Americans to get their updated COVID-19 vaccine, which protects against the original SARS-CoV-2 variant and BA.4 and BA.5 subvariants.

view more »

A CDC committee recommends the inclusion of COVID-19 vaccines in the 2023 immunization schedule; the administration releases a biodefense strategy.

view more »

CDC recommends for younger age groups updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

view more »

Effective Oct. 13, Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency determination.

view more »

HHS links COVID-19 vaccinations to fewer COVID-19 hospitalizations and deaths, and NIH details its plan to study long COVID-19 effects.

view more »

FDA now urges COVID-19 test developers to take traditional premarket review pathways, and HHS will cover the cost of 60,000 bebtelovimab doses.

view more »

America's Essential Hospitals urges HHS to codify a nondiscrimination standard and establish nondiscrimination training for all health care workers.

view more »

CDC updates guidance on infection control for health care personnel and staff shortages, as well as its global pandemic response strategy.

view more »

AHRQ published a primer detailing how hospitals and health systems can reduce their carbon footprint and protect communities from climate threats.

view more »

CDC reports lower in-hospital mortality rates from the omicron variant, providers have until Sept. 30 to report period 3 Provider Relief Fund spending.

view more »

America's Essential Hospitals urges CMS to swiftly restore full Medicare Part B drug payment rates for hospitals in the 340B Drug Pricing Program and define a select group of hospitals with a safety net mission.

view more »

The Biden administration's fall plan to manage the COVID-19 pandemic includes securing millions of updated vaccines and additional at-home, rapid tests; ensuring vaccine access for higher-risk Americans; and fostering community conversations about updated vaccines.

view more »

CDC recommends updated Pfizer and Moderna COVID-19 booster vaccines that target the BA.4 and BA.5 subvariants of SARS-CoV-2.

view more »

CMS on Aug. 29 finalized its decision to delay indefinitely implementation of the Radiation Oncology Model, which was scheduled to start Jan. 1, 2023.

view more »

No-cost, at-home COVID-19 tests no longer will be offered through the United States Postal Service, CDC releases a fall vaccination plan, and FDA warns prescribers about Paxlovid drug interactions.

view more »

The annual 340B Drug Pricing Program recertification period for hospitals began Aug. 24. Hospitals will have until Sept. 19 to complete the process.

view more »

Pfizer applies for emergency use authorization for its omicron-specific booster vaccine, the National Healthcare Safety Network will take over hospital data reporting, and CMS tells hospitals to brace for the public health emergency's end.

view more »

CDC updated its COVID-19 safety guidelines, FDA warned of false negative test risks, and bebtelovimab will transition to the commercial marketplace.

view more »

HHS releases two new reports on long COVID-19 research and support, while the Administration for Strategic Preparedness & Response shares guidance on Paxlovid efficacy and eligibility.

view more »

The declaration enables HHS to modify Medicare and Medicaid program requirements and could lead to more emergency funding for virus prevention and vaccines.

view more »

As monkeypox continues to spread, New York health leaders declare the virus an imminent threat, while California leaders request additional vaccine supply.

view more »

HHS agreed to purchase 66 million Moderna bivalent COVID-19 vaccine doses, while the CDC reported fewer vaccine reactions for those older than 50 who receive a second mRNA booster shot.

view more »

CDC recommends the Novavax COVID-19 vaccine for adults and reports that additional mRNA COVID-19 vaccine booster doses increase protection against moderate and severe COVID-19.

view more »

The Aug. 22 webinar will complement other federal resources on the annual 340B Drug Pricing Program recertification period for hospitals, open from Aug. 24 to Sept. 19.

view more »

FDA approves the Novavax COVID-19 vaccine for those 18 and older as the Biden-Harris administration releases an action plan to take on the BA.5 subvariant.

view more »

Effective July 15, Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency determination.

view more »
Load More
Previous Next
Close
Test Caption
Test Description goes like this